Dr. Michael Dickinson | ICML 2017 | Tazemetostat in FL and DLBCL

Anne Villeneuve

Michael Dickinson

Jun 22, 2017

Tazemetostat in FL and DLBCL

More about...

Aggressive B-cell lymphomas Anne Villeneuve Diffuse large B-cell lymphoma ICML 2017 Michael Dickinson Tazemetostat

ICML 2019 | RG6146 and venetoclax in DLBCL

During ICML 2019, the Lymphoma Hub were pleased to speak to Michael Dickinson, Peter MacCallum Cancer Center, Melbourne, AU, about a study investigating the combination of RG6146, venetoclax and rituximab in...

Jun 27, 2019

ICML 2019 | RG6146 and venetoclax in DLBCL

During ICML 2019, the Lymphoma Hub were pleased to speak to Michael Dickinson, Peter MacCallum Cancer Center, Melbourne, AU, about a study investigating the...

Jun 27, 2019

ICML 2019 | Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL

Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL

Jun 26, 2019

ICML 2019 | Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL

Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL

Jun 26, 2019

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Dr. Michael Dickinson | ICML 2017 | Tazemetostat in FL and DLBCL

Anne Villeneuve

Michael Dickinson

Jun 22, 2017

More about...

Related articles

Jun 27, 2019

Jun 27, 2019

Jun 26, 2019

Jun 26, 2019

Newsletter